{"name": "GenKyoTex",
 "permalink": "genkyotex",
 "crunchbase_url": "http://www.crunchbase.com/company/genkyotex",
 "homepage_url": "http://www.genkyotex.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@genkyotex.com",
 "phone_number": "+ 41 (0) 22 880 10 25",
 "description": " Treatment of Pathologies",
 "created_at": "Tue Jun 09 09:51:57 UTC 2009",
 "updated_at": "Wed Apr 03 05:27:03 UTC 2013",
 "overview": "\u003Cp\u003EGenKyoTex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals.  Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety and efficacy over existing antioxidants therapy, giving them a significant competitive advantage. GenKyoTex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       62],
      "assets/images/resized/0004/7604/47604v1-max-150x150.jpg"],
     [[189,
       79],
      "assets/images/resized/0004/7604/47604v1-max-250x250.jpg"],
     [[189,
       79],
      "assets/images/resized/0004/7604/47604v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman",
    "person":
     {"first_name": "Jes\u00c3\u00bas",
      "last_name": "Martin-Garcia",
      "permalink": "jess-martin-garcia",
      "image": null}},
   {"is_past": false,
    "title": "General Manager, CSO",
    "person":
     {"first_name": "Patrick",
      "last_name": "Page",
      "permalink": "patrick-page",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$51.8M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "",
    "source_description": "Capital Funding Report",
    "raised_amount": 3820000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 5,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Societe Generale  Asset Management",
         "permalink": "sg-asset-management-private-equity",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0004/4782/44782v1-max-150x150.png"],
             [[250,
               37],
              "assets/images/resized/0004/4782/44782v1-max-250x250.png"],
             [[281,
               42],
              "assets/images/resized/0004/4782/44782v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 1550000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 1,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Eclosion SA",
         "permalink": "eclosion-sa",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0008/5426/85426v1-max-150x150.jpg"],
             [[205,
               81],
              "assets/images/resized/0008/5426/85426v1-max-250x250.jpg"],
             [[205,
               81],
              "assets/images/resized/0008/5426/85426v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.reuters.com/article/2011/05/24/idUS48702+24-May-2011+HUG20110524",
    "source_description": "GenKyoTex raises CHF 18 million in a Series C Venture Financing to develop NOX enzyme inhibitors",
    "raised_amount": 20400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Edmond de Rothschild Investment Partners",
         "permalink": "edmond-de-rothschild-investment-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vesalius Biocapital Partners",
         "permalink": "vesalius-biocapital-partners",
         "image":
          {"available_sizes":
            [[[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-150x150.jpg"],
             [[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-250x250.jpg"],
             [[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MP Healthcare Venture Management",
         "permalink": "mp-healthcare-venture-management-inc",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0005/0688/50688v3-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0005/0688/50688v3-max-250x250.png"],
             [[450,
               52],
              "assets/images/resized/0005/0688/50688v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Eclosion SA",
         "permalink": "eclosion-sa",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0008/5426/85426v1-max-150x150.jpg"],
             [[205,
               81],
              "assets/images/resized/0008/5426/85426v1-max-250x250.jpg"],
             [[205,
               81],
              "assets/images/resized/0008/5426/85426v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fondation d'Aide aux Entreprises",
         "permalink": "fondation-daide-aux-entreprises",
         "image": null},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://finance.yahoo.com/news/genkyotex-raises-chf25-million-series-070000381.html",
    "source_description": "Genkyotex Raises CHF25 Million in Series C Round Extension",
    "raised_amount": 26000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 7,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Eclosion SA",
         "permalink": "eclosion-sa",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0008/5426/85426v1-max-150x150.jpg"],
             [[205,
               81],
              "assets/images/resized/0008/5426/85426v1-max-250x250.jpg"],
             [[205,
               81],
              "assets/images/resized/0008/5426/85426v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Edmond de Rothschild Investment Partners",
         "permalink": "edmond-de-rothschild-investment-partners",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vesalius Biocapital Partners",
         "permalink": "vesalius-biocapital-partners",
         "image":
          {"available_sizes":
            [[[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-150x150.jpg"],
             [[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-250x250.jpg"],
             [[140,
               77],
              "assets/images/resized/0006/1558/61558v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MP Healthcare Venture Management",
         "permalink": "mp-healthcare-venture-management-inc",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0005/0688/50688v3-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0005/0688/50688v3-max-250x250.png"],
             [[450,
               52],
              "assets/images/resized/0005/0688/50688v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "14, Chemin des Aulx",
    "address2": "Plan-Les-Ouates",
    "zip_code": "CH-1228",
    "city": "Geneva",
    "state_code": null,
    "country_code": "CHE",
    "latitude": 46.1685443,
    "longitude": 6.1036257}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        80],
       "assets/images/resized/0004/7603/47603v1-max-150x150.jpg"],
      [[250,
        134],
       "assets/images/resized/0004/7603/47603v1-max-250x250.jpg"],
      [[450,
        242],
       "assets/images/resized/0004/7603/47603v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}